Femasys (FEMY) Enterprise Value (2020 - 2026)
Femasys' (FEMY) quarterly Enterprise Value came in at -$5.4 million in Q1 2026, down 40.99% YoY from -$9.1 million in Q1 2025, and up 41.88% on a QoQ basis from -$9.3 million in Q4 2025.
Femasys (FEMY) Enterprise Value (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Enterprise Value data on file, last reported at -$5.4 million in Q1 2026.
- Quarterly Enterprise Value fell 40.99% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 40.99% YoY) and the FY2025 annual result came in at -$9.3 million, down 168.45% from the prior year.
- Enterprise Value rose to -$5.4 million in Q1 2026, from -$9.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3.2 million in Q2 2025 to a low of -$21.8 million in Q1 2022.
- A 5-year average of -$11.2 million and a median of -$10.2 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value jumped 84.11% — and 2025, when it tumbled 168.45%.
- Tracing FEMY's Enterprise Value over 5 years: stood at -$13.0 million in 2022, then sank by 67.54% to -$21.7 million in 2023, then jumped by 84.11% to -$3.5 million in 2024, then plunged by 168.45% to -$9.3 million in 2025, then soared by 41.88% to -$5.4 million in 2026.
- The last three Enterprise Value figures came in at -$5.4 million (Q1 2026), -$9.3 million (Q4 2025), and -$4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | -5.09 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | -863.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | -1.36 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | -1.47 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 4.83 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -403.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -138.60 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | -2.18 Bn |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.39 Mn |
| Dec 31, 2025 | -9.27 Mn |
| Sep 30, 2025 | -4.57 Mn |
| Jun 30, 2025 | -3.22 Mn |
| Mar 31, 2025 | -3.82 Mn |
| Dec 31, 2024 | -3.45 Mn |
| Sep 30, 2024 | -7.61 Mn |
| Jun 30, 2024 | -13.53 Mn |
| Mar 31, 2024 | -17.84 Mn |
| Dec 31, 2023 | -21.72 Mn |
| Sep 30, 2023 | -8.69 Mn |
| Jun 30, 2023 | -10.71 Mn |
| Mar 31, 2023 | -10.16 Mn |
| Dec 31, 2022 | -12.96 Mn |
| Sep 30, 2022 | -16.01 Mn |
| Jun 30, 2022 | -19.12 Mn |
| Mar 31, 2022 | -21.77 Mn |
| Dec 31, 2021 | -24.78 Mn |
| Sep 30, 2021 | -27.28 Mn |
| Jun 30, 2021 | -29.86 Mn |